These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37838100)
1. Liposomes - Human phagocytes interplay in whole blood: effect of liposome design. Giambelluca M; Markova E; Louet C; Steinkjer B; Sundset R; Škalko-Basnet N; Hak S Nanomedicine; 2023 Nov; 54():102712. PubMed ID: 37838100 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Allen TM; Hansen C Biochim Biophys Acta; 1991 Sep; 1068(2):133-41. PubMed ID: 1911826 [TBL] [Abstract][Full Text] [Related]
3. The immune-stimulation capacity of liposome-treated red blood cells. da Silveira Cavalcante L; Branch DR; Duong TT; Yeung RSM; Acker JP; Holovati JL J Liposome Res; 2018 Sep; 28(3):173-181. PubMed ID: 28276279 [TBL] [Abstract][Full Text] [Related]
4. Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes. Schroit AJ; Madsen J; Nayar R Chem Phys Lipids; 1986; 40(2-4):373-93. PubMed ID: 3527460 [TBL] [Abstract][Full Text] [Related]
5. Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells. Engel A; Chatterjee SK; Al-arifi A; Riemann D; Langner J; Nuhn P Pharm Res; 2003 Jan; 20(1):51-7. PubMed ID: 12608536 [TBL] [Abstract][Full Text] [Related]
7. An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes. Crielaard BJ; Yousefi A; Schillemans JP; Vermehren C; Buyens K; Braeckmans K; Lammers T; Storm G J Control Release; 2011 Dec; 156(3):307-14. PubMed ID: 21803084 [TBL] [Abstract][Full Text] [Related]
8. Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats. Moghimi SM; Patel HM Biochim Biophys Acta; 1996 Nov; 1285(1):56-64. PubMed ID: 8948475 [TBL] [Abstract][Full Text] [Related]
9. In vitro activation and maturation of human mononuclear phagocytes by stimulation with liposomes coated with a neoglycolipid containing α1-3, α1-6-mannotriose. Matsuoka Y; Kawauchi Y; Kawauchi K; Takiyama A; Kojima S; Kuroda Y; Kojima N Glycoconj J; 2019 Jun; 36(3):185-197. PubMed ID: 31016559 [TBL] [Abstract][Full Text] [Related]
10. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. Allen TM; Everest JM J Pharmacol Exp Ther; 1983 Aug; 226(2):539-44. PubMed ID: 6875864 [TBL] [Abstract][Full Text] [Related]
11. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes. Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158 [TBL] [Abstract][Full Text] [Related]
12. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Allen TM; Austin GA; Chonn A; Lin L; Lee KC Biochim Biophys Acta; 1991 Jan; 1061(1):56-64. PubMed ID: 1995057 [TBL] [Abstract][Full Text] [Related]
13. Liposome-encapsulated hemoglobin modulates lipopolysaccharide-induced tumor necrosis factor-alpha production in mice. Rudolph AS; Cliff R; Kwasiborski V; Neville L; Abdullah F; Rabinovici R Crit Care Med; 1997 Mar; 25(3):460-8. PubMed ID: 9118663 [TBL] [Abstract][Full Text] [Related]
14. Reduction of donor mononuclear phagocytes with clodronate-liposome during ex vivo lung perfusion attenuates ischemia-reperfusion injury. Yamanashi K; Ohsumi A; Oda H; Tanaka S; Yamada Y; Nakajima D; Date H J Thorac Cardiovasc Surg; 2023 Apr; 165(4):e181-e203. PubMed ID: 36404143 [TBL] [Abstract][Full Text] [Related]
15. Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin. Meng X; Zhang H; Chen L; Wang M; Zhang K; Liu X; Deng Y; Song Y AAPS PharmSciTech; 2023 Feb; 24(2):64. PubMed ID: 36759405 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Nanotargeted Liu SY; Lo SN; Lee WC; Hsu WC; Lee TW; Chang CH Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499267 [TBL] [Abstract][Full Text] [Related]
17. A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage 'suicide' technique. Claassen I; Van Rooijen N; Claassen E J Immunol Methods; 1990 Dec; 134(2):153-61. PubMed ID: 2147710 [TBL] [Abstract][Full Text] [Related]
18. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104 [TBL] [Abstract][Full Text] [Related]
19. In Vivo Quantification of Nanoparticle Association with Immune Cell Subsets in Blood. Ong YR; De Rose R; Johnston APR Adv Healthc Mater; 2021 May; 10(9):e2002160. PubMed ID: 33644997 [TBL] [Abstract][Full Text] [Related]
20. Role of Liposome Size, Surface Charge, and PEGylation on Rheumatoid Arthritis Targeting Therapy. Ren H; He Y; Liang J; Cheng Z; Zhang M; Zhu Y; Hong C; Qin J; Xu X; Wang J ACS Appl Mater Interfaces; 2019 Jun; 11(22):20304-20315. PubMed ID: 31056910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]